Pressure BioSciences Announces Launch of FDA-Registered Hand Sanitizer as First Product Developed Through Pending Merger Partners (PBIO)

PR Newswire SOUTH EASTON, Mass., May 14, 2020 SOUTH EASTON, Mass., May 14, 2020 /PRNewswire/ — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI”

Read more

Featured Interview: President Daryl Rebeck of Lexagene Hldgs Inc. (OTCQB: LXXGF)

President Daryl Rebeck of Lexagene Hldgs Inc., joins the show to discuss developing a commercialized and easy to use genetic analyzer for use in multiple markets.

Read more

Interview: CEO Aitan Zacharin of Greater Cannabis Co Inc. (OTCQB: GCAN)

CEO Aitan Zacharin of Greater Cannabis Co Inc., talks about commercializing patented thin-film biotechnology for use in the delivery of cannabinoids.

Read more

GT Biopharma Receives Institutional Review Board Approval to Proceed With in Human FDA Phase 1 Clinical Trial

TAMPA, Florida, April 8, 2019 /CNW/ –GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology biotechnology company focused on innovative treatments based on

Read more

Biostage Reports 2018 Financial Results

– Pre-clinical and human compassionate use clinical evidence support IND filing mid-year 2019 HOLLISTON, Mass., March 28, 2019 /PRNewswire/ — Biostage, Inc. (OTCQB: BSTG)

Read more

Featured Interview: CEO James McGorry of Biostage, Inc. (OTCQB: BSTG)

CEO James McGorry of Biostage, Inc., discusses 2019 plans to transition into a clinical company, investment into the Chinese market, and spreading their technology to those in need.

Read more

Interview: CEO James McGorry of Biostage, Inc. (OTCQB: BSTG)

CEO James McGorry of Biostage, Inc., discusses details of being a regenerative biotechnology company, developing bio engineered organ implants, and entering into clinical trials.

Read more